TrialJCI insight2022

Postprandial metabolism of apolipoproteins B48, B100, C-III, and E in humans with APOC3 loss-of-function mutations.

Marja-Riitta Taskinen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.